JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, I. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, I. D
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*High Risk Pregnancy
J Clin Pathol 2000; 53:573-580
© 2000 Journal of Clinical Pathology


Leader

Thrombophilia in pregnancy

Isobel D Walker1

1 Haematology Department, 3rd Floor, Macewen Building, Glasgow Royal Infirmary, Castle Street, Glasgow G4 0SF, UK

Dr Walker email: idw{at}idwhaem.demon.co.uk Thrombophilia can be defined as a predisposition to thrombosis. Abnormalities in haemostasis that are associated with clinical thrombophilia include heritable defects, such as mutations in the genes encoding the natural anticoagulants antithrombin, protein C, and protein S, or clotting factors prothrombin and factor V, and acquired defects, such as antiphospholipids. Women with thrombophilic defects have been shown to be at increased risk, not only of pregnancy associated thromboembolism, but also of other vascular complications of pregnancy, including pre-eclampsia and fetal loss. Routine thrombophilia screening of all women attending antenatal clinics is not recommended. Because some thrombophilic defects—for example, type 1 antithrombin deficiency and antiphospholipids—are associated with a high risk of recurrent thrombosis or other pregnancy complications, it is suggested that selected women (those with a personal or confirmed family history of venous thromboembolism or with a history of recurrent fetal loss) are screened for these defects to allow pregnancy management planning.

Key Words: thrombophilia • pregnancy




This article has been cited by other articles:


Home page
Obstet GynecolHome page
J. N. Quinones, D. N. James, D. M. Stamilio, K. L. Cleary, and G. A. Macones
Thromboprophylaxis After Cesarean Delivery: A Decision Analysis
Obstet. Gynecol., October 1, 2005; 106(4): 733 - 740.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K.V. N. Menon, V. Shah, and P. S. Kamath
The Budd-Chiari Syndrome
N. Engl. J. Med., February 5, 2004; 350(6): 578 - 585.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
A. Dossenbach-Glaninger, M. van Trotsenburg, M. Dossenbach, C. Oberkanins, A. Moritz, W. Krugluger, J. Huber, and P. Hopmeier
Plasminogen Activator Inhibitor 1 4G/5G Polymorphism and Coagulation Factor XIII Val34Leu Polymorphism: Impaired Fibrinolysis and Early Pregnancy Loss
Clin. Chem., July 1, 2003; 49(7): 1081 - 1086.
[Abstract] [Full Text] [PDF]


Home page
ANGIOLOGYHome page
T. Harada, H. Morita, Y. Imai, D. Hayashi, N. Takeda, K. Maemura, Y. Yazaki, and R. Nagai
Deficiency of Protein S-Mediated Familial Venous Thrombophilia: A Case Report
Angiology, May 1, 2003; 54(3): 377 - 381.
[Abstract] [PDF]


Home page
Mol Hum ReprodHome page
N. Kanayama, K. Takahashi, T. Matsuura, M. Sugimura, T. Kobayashi, N. Moniwa, M. Tomita, and K. Nakayama
Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice
Mol. Hum. Reprod., December 1, 2002; 8(12): 1129 - 1135.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
T.M. Rahman and J. Wendon
Severe hepatic dysfunction in pregnancy
QJM, June 1, 2002; 95(6): 343 - 357.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
D. Prasmusinto, S. Skrablin, C. Hofstaetter, R. Fimmers, and K. van der Ven
The Methylenetetrahydrofolate Reductase 677 C->T Polymorphism and Preeclampsia in Two Populations
Obstet. Gynecol., June 1, 2002; 99(6): 1085 - 1092.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
S Donohoe, S Quenby, I Mackie, G Panal, R Farquharson, R Malia, J Kingdom, and S Machin
Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal andheparin-treated antiphospholipid syndrome pregnancies
Lupus, January 1, 2002; 11(1): 11 - 20.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.